Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C159540
http://purl.obolibrary.org/obo/NCIT_C159540
|
|---|---|
| Preferred Name | Oral Cancer Vaccine V3-OVA |
| Definitions |
An orally available cancer vaccine composed of autologous ovarian cancer antigens obtained from hydrolyzed, inactivated blood and tumor tissue of patients with ovarian cancer, with potential immunostimulatory and antineoplastic activities. Upon oral administration of the oral cancer vaccine V3-OVA, the ovarian cancer antigens stimulate the immune system and activate a cytotoxic T-lymphocyte (CTL) immune response against ovarian cancer cells.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | An orally available cancer vaccine composed of autologous ovarian cancer antigens obtained from hydrolyzed, inactivated blood and tumor tissue of patients with ovarian cancer, with potential immunostimulatory and antineoplastic activities. Upon oral administration of the oral cancer vaccine V3-OVA, the ovarian cancer antigens stimulate the immune system and activate a cytotoxic T-lymphocyte (CTL) immune response against ovarian cancer cells. |
|---|---|
| prefLabel | Oral Cancer Vaccine V3-OVA
|
| label | Oral Cancer Vaccine V3-OVA
|
| NCI_META_CUI | CL951378
|
| PDQ_Closed_Trial_Search_ID | 797490
|
| code | C159540
|
| prefixIRI | NCIT:C159540
|
| in_subset | |
| Preferred_Name | Oral Cancer Vaccine V3-OVA
|
| Maps_To | Oral Cancer Vaccine V3-OVA
|
| NCI_Drug_Dictionary_ID | 797490
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 797490
|
| Semantic_Type | Pharmacologic Substance
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |